Biomarker Research and Inflammatory Diseases
May 28th, 2006According to a recent article by HealthDay News, an international team of scientists has identified new biomarkers that could help develop improved treatments for spondylarthritis (SpA).
SpA refers to a group of chronic autoimmune conditions, including ankylosing spondylitis and arthritis associated with psoriasis and inflammatory bowel diseases, primarily those affecting the peripheral joints.
In this study of 52 SpA patients, researchers identified the new biomarkers after analyzing tissue from the synovium, the thin membrane lining the joint space and the primary target of inflammation. The researchers found that changes in SpA disease activity are accompanied by a series of distinct and measurable events in synovial tissue.
Click here for details…